Buyback yield (TTM)
4.22%
Shareholder yield (TTM)
5.30%
5Y share count change
-4.0%
Buyback spend (TTM)
$744.30M
Cumulative buybacks
$8.94B
Key takeaways
- Zimmer Biomet Holdings (ZBH) repurchased about $744.30M of stock over the trailing twelve months.
- Diluted share count is down 4.0% over the last ~5 fiscal years — buybacks are net-shrinking the share base.
- TTM buyback ÷ stock-based-comp ratio of 7.85× — repurchases more than cover SBC dilution.
- TTM repurchases used about 45% of free cash flow remaining after dividends.
Dividend & buyback yield over time for Zimmer Biomet Holdings (ZBH)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for Zimmer Biomet Holdings (ZBH)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for Zimmer Biomet Holdings (ZBH)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for Zimmer Biomet Holdings (ZBH)
Latest: $487.00M
Overview
2025's annual buyback spend for Zimmer Biomet Holdings (ZBH) came in at $487.00M – plunged 43.9% year-over-year.
Over 2015–2025 (10 years), Zimmer Biomet Holdings buyback spend expanded at a +12.5% compound annual rate, with mixed annual results across the window.
Zimmer Biomet Holdings buyback spend plunged from $1.05B in 2011 to $487.00M in 2025, a 53.6% drawdown.
$1.05B stands as the all-time-high annual buyback spend, posted in 2011, against a low of $0.00 during 1998.
Zimmer Biomet Holdings Buyback Spend 2025: $487.00M
2025's buyback spend for Zimmer Biomet Holdings came in at $487.00M, plunged 43.9% below 2024.
Zimmer Biomet Holdings Buyback Spend 2024: $868.00M
Zimmer Biomet Holdings posted buyback spend of $868.00M in 2024, grew 25.4% from 2023.
Zimmer Biomet Holdings Buyback Spend 2023: $692.20M
In 2023, Zimmer Biomet Holdings reported buyback spend of $692.20M, surged 447.6% from 2022.
Zimmer Biomet Holdings Buyback Spend 2022: $126.40M
Zimmer Biomet Holdings buyback spend in 2022 was $126.40M.
Zimmer Biomet Holdings Buyback Spend 2021: $0.00
Zimmer Biomet Holdings buyback spend in 2021 was $0.00.
See more financial history for Zimmer Biomet Holdings (ZBH).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2025 | $487.00M | $0.00 | $487.00M | 2.75% | 0.20B | -2.6% | |
| 2024 | $868.00M | $101.00M | $767.00M | 4.13% | 0.20B | -2.8% | |
| 2023 | $692.20M | $99.80M | $592.40M | 2.74% | 0.21B | -0.3% | |
| 2022 | $126.40M | $105.00M | $21.40M | 0.47% | 0.21B | -0.0% | |
| 2021 | $0.00 | $76.00M | −$76.00M | — | 0.21B | +1.6% | |
| 2020 | $0.00 | $73.80M | −$73.80M | — | 0.21B | +0.1% | |
| 2019 | $0.00 | $84.30M | −$84.30M | — | 0.21B | +1.6% | |
| 2018 | $0.00 | $65.50M | −$65.50M | — | 0.20B | -0.1% | |
| 2017 | $0.00 | $53.70M | −$53.70M | — | 0.20B | +0.6% | |
| 2016 | $415.50M | $57.30M | $358.20M | 2.07% | 0.20B | +6.6% | |
| 2015 | $150.00M | $46.40M | $103.60M | 0.75% | 0.19B | +10.5% | |
| 2014 | $400.90M | $49.40M | $351.50M | 2.14% | 0.17B | -0.1% | |
| 2013 | $720.80M | $48.50M | $672.30M | 4.67% | 0.17B | -2.4% | |
| 2012 | $485.60M | $55.00M | $430.60M | 4.45% | 0.18B | -6.7% | |
| 2011 | $1.05B | $60.50M | $989.50M | 11.42% | 0.19B | -6.2% | |
| 2010 | $505.60M | $62.00M | $443.60M | 5.04% | 0.20B | -6.8% | |
| 2009 | $923.70M | $75.30M | $848.40M | 7.94% | 0.22B | -5.5% | |
| 2008 | $737.00M | $69.90M | $667.10M | 8.49% | 0.23B | -3.9% | |
| 2007 | $576.30M | $0.00 | $576.30M | 3.86% | 0.24B | -3.2% | |
| 2006 | $798.80M | $0.00 | $798.80M | 4.43% | 0.25B | -1.8% | |
| 2005 | $4.10M | $0.00 | $4.10M | 0.03% | 0.25B | +0.8% | |
| 2004 | $0.00 | $0.00 | $0.00 | — | 0.25B | +17.3% | |
| 2003 | $0.00 | $0.00 | $0.00 | — | 0.21B | +7.3% | |
| 2002 | $0.00 | $0.00 | $0.00 | — | 0.20B | +1.3% | |
| 2001 | $0.00 | $0.00 | $0.00 | — | 0.19B | +0.4% | |
| 2000 | $0.00 | $0.00 | $0.00 | — | 0.19B | 0.0% | |
| 1999 | $0.00 | $0.00 | $0.00 | — | 0.19B | -0.1% | |
| 1998 | $0.00 | $0.00 | $0.00 | — | 0.19B | — |
- 2025$487.00M
- 2024$868.00M
- 2023$692.20M
- 2022$126.40M
- 2021$0.00
- 2020$0.00
- 2019$0.00
- 2018$0.00
- 2017$0.00
- 2016$415.50M
- 2015$150.00M
- 2014$400.90M
- 2013$720.80M
- 2012$485.60M
- 2011$1.05B
- 2010$505.60M
- 2009$923.70M
- 2008$737.00M
- 2007$576.30M
- 2006$798.80M
- 2005$4.10M
- 2004$0.00
- 2003$0.00
- 2002$0.00
- 2001$0.00
- 2000$0.00
- 1999$0.00
- 1998$0.00
Buybacks vs stock-based compensation for Zimmer Biomet Holdings (ZBH)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 7.85×.
Buybacks vs dividends (share of cash returned) for Zimmer Biomet Holdings (ZBH)
How Zimmer Biomet Holdings splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as Zimmer Biomet Holdings, ranked by their latest buyback spend.
| $5.95B | |
| $5.54B | |
| $5.08B | |
| $4.11B | |
| $980.00M | |
| $216.35M | |
| $0.00 | |
| $0.00 |
- $5.95B
- $5.54B
- $5.08B
- $4.11B
- $980.00M
- $216.35M
- $0.00
- $0.00
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $1.65B (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation